These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 1980832

  • 1. Current status of toremifene, a new antiestrogenic agent for the treatment of breast cancer. A symposium. San Antonio, TX, USA, December 7, 1989.
    Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S1-54. PubMed ID: 1980832
    [No Abstract] [Full Text] [Related]

  • 2. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
    Konstantinova MM, Gershanovich MA.
    Vopr Onkol; 1990 Aug; 36(10):1182-6. PubMed ID: 2147527
    [Abstract] [Full Text] [Related]

  • 3. Development and biochemical pharmacology of toremifene, an antiestrogenic antitumor drug.
    Kangas L.
    Acta Obstet Gynecol Scand; 1991 Aug; 70(4-5):399. PubMed ID: 1836089
    [No Abstract] [Full Text] [Related]

  • 4. Toremifene, a new antiestrogenic compound in the treatment of metastatic mammary cancer. A phase II study.
    Gundersen S.
    J Steroid Biochem; 1990 Jun 22; 36(3):233-4. PubMed ID: 2142241
    [Abstract] [Full Text] [Related]

  • 5. Phase III studies of toremifene in metastatic breast cancer.
    Pyrhönen SO.
    Breast Cancer Res Treat; 1990 Aug 22; 16 Suppl():S41-6. PubMed ID: 2149285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Introduction to toremifene.
    Kangas L.
    Breast Cancer Res Treat; 1990 Aug 22; 16 Suppl():S3-7. PubMed ID: 2149282
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A phase I trial of toremifene, a new antiestrogen.
    Hamm JT.
    Cancer Invest; 1990 Aug 22; 8(2):273-4. PubMed ID: 2144786
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study.
    Valavaara R, Pyrhönen S, Heikkinen M, Rissanen P, Blanco G, Thölix E, Nordman E, Taskinen P, Holsti L, Hajba A.
    Eur J Cancer Clin Oncol; 1988 Apr 22; 24(4):785-90. PubMed ID: 2968265
    [Abstract] [Full Text] [Related]

  • 14. The significance of estrogen receptors in tamoxifen and toremifene therapy.
    Valavaara R, Kangas L.
    Ann Clin Res; 1988 Apr 22; 20(5):380-8. PubMed ID: 2975479
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer.
    Bishop J, Murray R, Webster L, Pitt P, Stokes K, Fennessy A, Olver I, Leber G.
    Cancer Chemother Pharmacol; 1992 Apr 22; 30(3):174-8. PubMed ID: 1385761
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiestrogen therapy for breast cancer: current strategies and future prospects.
    Jordan VC, Tormey DC.
    Cancer Treat Res; 1988 Apr 22; 39():97-110. PubMed ID: 2908611
    [Abstract] [Full Text] [Related]

  • 19. Antiestrogens proving their potential.
    Smigel K.
    J Natl Cancer Inst; 1990 Jan 17; 82(2):87-8. PubMed ID: 2136757
    [No Abstract] [Full Text] [Related]

  • 20. Alternative mechanism of action of "anti-oestrogens" in breast cancer.
    Ebbs SR, Roberts JV, Baum M.
    Lancet; 1987 Sep 12; 2(8559):621. PubMed ID: 2887899
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.